Total investments 8
Average round size 
$22M
The average size of a deal this fund participated in
Portfolio companies 6
Rounds per year 2.00
Lead investments 1
Follow on index
0.25How often the fund supports its portfolio startups at next rounds
Exits 1
Key employees Soon
Vancouver, British Columbia, Canada Related Funds
Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of adMare Bio Innovations:
Typical Co-investors
adMare Bio Innovations is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after adMare Bio Innovations:
There are no funds here. If we find new data, we will add it here.
Look at other 50 related and similar funds Collapse list ↓
| Fund Name | Location |
| Canadian Solar | Canada, Guelph, Ontario |
| Coastview Capital | California, Los Angeles, United States |
| Coplex | Arizona, Phoenix, United States |
| Dongfang Ruijia Touzi | China, Guangdong, Shenzhen |
| Drake Enterprises | Franklin, North Carolina, United States |
| Edelweiss Tokio Life Insurance | India, Maharashtra, Mumbai |
| Frost Venture Partners | California, San Juan Capistrano, United States |
| GREE Ventures | Chiyoda, Japan |
| HHIAB | - |
| IQbility | Attiki, Greece, Kallithéa |
| KB Global Platform Fund | Seoul, Seoul-t'ukpyolsi, South Korea |
| Mihe Capital | - |
| Nanshan Venture Capital | China, Guangdong, Shenzhen |
| Poland Prize Program | - |
| Purple Cow | Brentwood, California, United States |
| Sime Darby | Kuala Lumpur, Malaysia |
| Soros Fund Management | New York, New York, United States |
| Times Mirror Interactive | California, Los Angeles, United States |
| Tongjian Tailite | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Specific Biologics | 10 Oct 2023 | Ontario, California, United States | |||
Inversago Pharma | $75M | 17 Oct 2022 | Montreal, Quebec, Canada | ||
Immugenia | 06 Oct 2022 | Sherbrooke, Quebec, Canada | |||
Domain Therapeutics | $46M | 10 May 2022 | France, Grand Est, France | ||
Specific Biologics | 16 Dec 2021 | Ontario, California, United States | |||
Inversago Pharma | $35M | 08 Sep 2020 | Quebec | ||
Bright Angel Therapeutics | 03 Dec 2019 | Old Toronto, Ontario, Canada |
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
To post a comment or write a complain, please sign in with LinkedIn
Review
- No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Do you represent adMare Bio Innovations?
Get access to manage this page
Found incorrect info? Let us know!
Total investments 8
Average round size 22M
Rounds per year 2.00
Peak activity year 2022
Lead investments 1
Follow on index 0.25
Exits 1
Group Appearance index 1.00
Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Specific Biologics | 10 Oct 2023 | Ontario, California, United States | |||
Inversago Pharma | $75M | 17 Oct 2022 | Montreal, Quebec, Canada | ||
Immugenia | 06 Oct 2022 | Sherbrooke, Quebec, Canada | |||
Domain Therapeutics | $46M | 10 May 2022 | France, Grand Est, France | ||
Specific Biologics | 16 Dec 2021 | Ontario, California, United States | |||
Inversago Pharma | $35M | 08 Sep 2020 | Quebec | ||
Bright Angel Therapeutics | 03 Dec 2019 | Old Toronto, Ontario, Canada |
